NGEN NervGen posts narrow Q3 beat as clinical pipeline advances CEO reaffirms confidence in nerve repair therapy FMFC Kandal M lays out multiyear digital payment penetration targets in its latest quarterly update Markel Group MKL Stock Why Financial Strength Marginal Gain 20260420 KRAKacquisition KRAQU Stock Is It a Compelling Buy KRAQU Earnings KRAKacquisition reports no earnings amid SPAC merger search The macro factors Intrepid Potash IPI discussed in earnings IPI Q1 2026 Intrepid Potash Beats Estimates by 28